526,711 RSUs awarded to Hims & Hers (NYSE: HIMS) policy chief

Rhea-AI Filing Summary

Autor Deborah M. reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that Chief Policy Officer Deborah M. Autor received a grant of 526,711 Restricted Stock Units (RSUs), each representing a right to receive one share of Class A common stock. The RSUs vest over four years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, beginning on March 15, 2026. Following this award, she holds 526,711 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Autor Deborah M.

Role Chief Policy Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	526,711	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 526,711 shares (Direct)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on March 15, 2026.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Autor Deborah M.

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Policy Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		526,711		(2)	(2)	Class A Common Stock	526,711	$0	526,711	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on March 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Deborah M Autor	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hims & Hers (HIMS) disclose for Deborah M. Autor?

Hims & Hers disclosed that Chief Policy Officer Deborah M. Autor received a grant of 526,711 Restricted Stock Units. Each RSU represents a contingent right to one share of Class A common stock, awarded as part of her equity-based compensation package.

How many RSUs were granted to the Hims & Hers Chief Policy Officer?

Deborah M. Autor was granted 526,711 Restricted Stock Units. These RSUs give her the right to receive an equal number of Class A common shares, subject to vesting conditions tied to continued service with Hims & Hers Health, Inc. over a multi-year period.

What are the vesting terms of the 526,711 RSUs at Hims & Hers (HIMS)?

The 526,711 RSUs vest over four years in substantially equal quarterly installments. Vesting occurs on March 15, June 15, September 15 and December 15 of each year, with the first vesting date scheduled for March 15, 2026, assuming service-based conditions are met.

When does vesting begin for Deborah M. Autor’s RSU grant at HIMS?

Vesting for Deborah M. Autor’s RSU grant begins on March 15, 2026. From that date, the 526,711 RSUs vest in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, contingent on satisfying service-based vesting requirements.

What type of security did Hims & Hers grant to its Chief Policy Officer?

Hims & Hers granted Restricted Stock Units, which are derivative equity awards. Each RSU represents a contingent right to receive one share of Class A common stock in the future, rather than an immediate cash payment, aligning compensation with the company’s equity performance.

How many RSUs does Deborah M. Autor hold after this Form 4 transaction?

After this transaction, Deborah M. Autor holds 526,711 Restricted Stock Units directly. This total corresponds to the full amount of the newly granted RSUs, reflecting her equity-based incentive position reported in the Form 4 insider filing for Hims & Hers Health, Inc.